Loading...

MIRM MIRUM PHARMACEUTICALS INC Other Situations 8-K Filing

MRM

MRM

MIRUM PHARMACEUTICALS INC

(MIRM)

2024 8-K

Show Summary

Summary

Financial Statements

Financial Results

Financial Results

Earnings Reports

Interim Results of Volixiba...

Annual Meeting of Stockholders

Earnings Reports

Financial Results Announcement

Management Promotion

Financial Results Announcement

Results Announcement

Acquisition and Private Pla...

FDA Review Extension

Appointment of CFO

Earnings Reports

Acquisition of Assets

Annual Meeting Results

Earnings Reports

Issuance of Convertible Sen...

Financial Results and Busin...

Appointment and Resignation

Closure of Silicon Valley Bank

Earnings Reports

Earnings Reports

External Links:

Mirum Pharmaceuticals announced positive interim results from Phase 2b studies of volixibat in patients with primary biliary cholangitis and primary sclerosing cholangitis, showing significant improvement in pruritus and fatigue.

AI Assistant

MIRUM PHARMACEUTICALS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.